Methodology: This study was a multi-centre, non-comparative Clinical In-Market Evaluation. A total of 153 patients were recruited across 72 centres in UK, Ireland, Holland, Germany, Spain and Canada during the study period of March to November 2008.
Results: The mean age of the 153 patients was 73 years (range of 22 to 99 years) of which 37.5% were male and 62.5% female. Treatment settings included hospital (36%), home (18%), wound clinic (37%), nursing home (7%) and other (3%). The median reference wound duration was 3 weeks (range of 0.1 weeks to 50 years). Clinician’s rated the dressing as acceptable for the indication treated in 95% of patients (145/152). There was significant evidence of a reduction in the reference wound area over all patients (p<0.001), with a median reduction at the final assessment of 69%. There was significant evidence of a reduction in the level of exudate in the reference wound between baseline and the final assessment (p<0.001). There was no reported pain on removal of the dressing in 93% of dressing removals.
Conclusion: The silicone adhesive hydrocellular foam dressing* was shown to be an effective dressing in conjunction with routine clinical practice in improving wound outcomes, in particular reducing wound area, depth and level of exudate.